BRAINSWAY LTD-ADR (BWAY) Fundamental Analysis & Valuation

NASDAQ:BWAY • US10501L1061

Current stock price

13.92 USD
-0.38 (-2.66%)
At close:
13.92 USD
0 (0%)
After Hours:

This BWAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. BWAY Profitability Analysis

1.1 Basic Checks

  • In the past year BWAY was profitable.
  • In the past year BWAY had a positive cash flow from operations.
  • BWAY had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: BWAY reported negative operating cash flow in multiple years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • BWAY has a better Return On Assets (5.53%) than 80.85% of its industry peers.
  • The Return On Equity of BWAY (8.92%) is better than 80.32% of its industry peers.
  • BWAY has a better Return On Invested Capital (2.75%) than 70.74% of its industry peers.
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROIC 2.75%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • BWAY has a Profit Margin of 12.73%. This is amongst the best in the industry. BWAY outperforms 86.17% of its industry peers.
  • BWAY has a Operating Margin of 5.78%. This is in the better half of the industry: BWAY outperforms 71.81% of its industry peers.
  • BWAY has a better Gross Margin (74.92%) than 84.57% of its industry peers.
  • BWAY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BWAY Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BWAY is destroying value.
  • BWAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • BWAY has an Altman-Z score of 7.81. This indicates that BWAY is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 7.81, BWAY belongs to the top of the industry, outperforming 84.57% of the companies in the same industry.
  • The Debt to FCF ratio of BWAY is 0.37, which is an excellent value as it means it would take BWAY, only 0.37 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BWAY (0.37) is better than 92.02% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that BWAY is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.08, BWAY is in the better half of the industry, outperforming 67.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Altman-Z 7.81
ROIC/WACC0.32
WACC8.47%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 3.19 indicates that BWAY has no problem at all paying its short term obligations.
  • The Current ratio of BWAY (3.19) is comparable to the rest of the industry.
  • A Quick Ratio of 3.02 indicates that BWAY has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.02, BWAY is in the better half of the industry, outperforming 63.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 3.02
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BWAY Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 117.91% over the past year.
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%

3.2 Future

  • The Earnings Per Share is expected to grow by 35.62% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 23.69% on average over the next years. This is a very strong growth
EPS Next Y25.19%
EPS Next 2Y39.53%
EPS Next 3Y35.62%
EPS Next 5YN/A
Revenue Next Year25.98%
Revenue Next 2Y26.09%
Revenue Next 3Y23.69%
Revenue Next 5YN/A

3.3 Evolution

BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1 1.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. BWAY Valuation Analysis

4.1 Price/Earnings Ratio

  • BWAY is valuated rather expensively with a Price/Earnings ratio of 22.10.
  • Based on the Price/Earnings ratio, BWAY is valued a bit cheaper than the industry average as 76.60% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of BWAY to the average of the S&P500 Index (26.86), we can say BWAY is valued inline with the index average.
  • A Price/Forward Earnings ratio of 17.63 indicates a rather expensive valuation of BWAY.
  • Based on the Price/Forward Earnings ratio, BWAY is valued cheaply inside the industry as 82.98% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.39, BWAY is valued rather cheaply.
Industry RankSector Rank
PE 22.1
Fwd PE 17.63
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BWAY is valued a bit cheaper than 65.43% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BWAY is valued a bit cheaper than the industry average as 76.60% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 30.38
EV/EBITDA 103.85
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BWAY's earnings are expected to grow with 35.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.88
PEG (5Y)N/A
EPS Next 2Y39.53%
EPS Next 3Y35.62%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BWAY Dividend Analysis

5.1 Amount

  • No dividends for BWAY!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BWAY Fundamentals: All Metrics, Ratios and Statistics

BRAINSWAY LTD-ADR

NASDAQ:BWAY (4/10/2026, 8:09:13 PM)

After market: 13.92 0 (0%)

13.92

-0.38 (-2.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11
Earnings (Next)05-11
Inst Owners5.26%
Inst Owner Change0.04%
Ins Owners15.17%
Ins Owner Change0%
Market Cap557.26M
Revenue(TTM)N/A
Net Income(TTM)6.25M
Analysts85.71
Price Target0.05 (-99.64%)
Short Float %N/A
Short Ratio0.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.34%
Min EPS beat(2)35.56%
Max EPS beat(2)95.12%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-22.64%
Max EPS beat(4)95.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-11.32%
Revenue beat(16)6
Avg Revenue beat(16)-26.49%
PT rev (1m)-59.44%
PT rev (3m)-59.64%
EPS NQ rev (1m)-51.02%
EPS NQ rev (3m)-51.14%
EPS NY rev (1m)-51.02%
EPS NY rev (3m)-48.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.87%
Valuation
Industry RankSector Rank
PE 22.1
Fwd PE 17.63
P/S 11.35
P/FCF 30.38
P/OCF 25.02
P/B 7.95
P/tB 7.95
EV/EBITDA 103.85
EPS(TTM)0.63
EY4.53%
EPS(NY)0.79
Fwd EY5.67%
FCF(TTM)0.46
FCFY3.29%
OCF(TTM)0.56
OCFY4%
SpS1.23
BVpS1.75
TBVpS1.75
PEG (NY)0.88
PEG (5Y)N/A
Graham Number4.98
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROCE 3.26%
ROIC 2.75%
ROICexc 15.43%
ROICexgc 15.43%
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
FCFM 37.36%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Debt/EBITDA 1.21
Cap/Depr 207.6%
Cap/Sales 8.01%
Interest Coverage 26.28
Cash Conversion 470.69%
Profit Quality 293.55%
Current Ratio 3.19
Quick Ratio 3.02
Altman-Z 7.81
F-Score5
WACC8.47%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
EPS Next Y25.19%
EPS Next 2Y39.53%
EPS Next 3Y35.62%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%
Revenue Next Year25.98%
Revenue Next 2Y26.09%
Revenue Next 3Y23.69%
Revenue Next 5YN/A
EBIT growth 1Y147.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.54%
EBIT Next 3Y43.13%
EBIT Next 5Y44.57%
FCF growth 1Y441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y749.36%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY Fundamental Analysis FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 5 / 10 to BWAY.


Can you provide the valuation status for BRAINSWAY LTD-ADR?

ChartMill assigns a valuation rating of 7 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.


Can you provide the profitability details for BRAINSWAY LTD-ADR?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


How financially healthy is BRAINSWAY LTD-ADR?

The financial health rating of BRAINSWAY LTD-ADR (BWAY) is 7 / 10.